With your own knowledge and the help of the following document:

Document 1 (Title: Management Approaches for Acetaminophen Toxicity): Paracetamol (acetaminophen) overdose represents a common and potentially life-threatening poisoning requiring evidence-based management approaches guided by pharmacokinetic and metabolic considerations. Initial interventions focus on reducing absorption, with substantial evidence supporting early activated charcoal administration when patients present within 1-2 hours post-ingestion. Multiple controlled studies document 50-70% reductions in paracetamol bioavailability following timely charcoal administration, significantly altering toxicity risk assessments. Gastrointestinal decontamination approaches include gastric lavage, which demonstrates particular utility when performed within 60 minutes of ingestion for substantial overdoses, representing an important intervention alongside activated charcoal in early presentations. The hepatotoxicity mechanism involves a complex metabolic pathway wherein a small percentage of paracetamol undergoes cytochrome P450-mediated (primarily CYP2E1) biotransformation generating the reactive intermediate N-acetyl-p-benzoquinone imine (NAPQI), which depletes glutathione and subsequently binds cellular proteins causing hepatocellular damage. Antidotal therapy with N-acetylcysteine works through multiple mechanisms including glutathione precursor provision and alternative metabolic pathway enhancement, with administration protocols varying between oral and intravenous routes. Importantly, concurrent administration of oral N-acetylcysteine with activated charcoal results in significant adsorption and reduced antidote bioavailability, necessitating dosage adjustments or separated administration when both interventions are indicated. Clinical progression typically follows a characteristic pattern, with hepatotoxicity markers including transaminase elevations developing 24-48 hours post-ingestion rather than presenting as early manifestations, contrasting with other toxic presentations where renal dysfunction may present earlier. These pharmacological and clinical characteristics inform evidence-based management approaches balancing gastrointestinal decontamination, antidotal therapy, and supportive care for optimal outcomes.
Document 2 (Title: Clinical Management of Acute Salicylism): Salicylate poisoning presents distinctive toxicological patterns requiring age-specific management approaches and targeted interventions addressing multiple pathophysiological derangements. Pediatric considerations assume particular importance, with children demonstrating increased susceptibility to toxic effects at lower relative doses compared to adults due to immature metabolic pathways, limited glycogen stores, and reduced buffering capacity. These age-related differences necessitate more aggressive intervention thresholds and closer monitoring parameters when managing suspected pediatric exposures. Gastrointestinal decontamination approaches include considerations regarding activated charcoal administration, which should be implemented following rather than during gastric lavage procedures when both interventions are indicated, as concurrent administration reduces lavage efficacy through material binding while potentially increasing aspiration risk. Acid-base management represents a cornerstone of treatment, with intravenous sodium bicarbonate serving dual therapeutic purposes: correcting the characteristic metabolic acidosis while simultaneously alkalinizing urine to enhance salicylate elimination through ion trapping mechanisms. This alkalinization approach significantly increases renal clearance, with studies demonstrating 5-10 fold improvements in elimination rates when urinary pH exceeds 7.5 compared to acidic urine conditions. Respiratory manifestations follow predictable patterns, with hyperventilation representing an early compensatory response to metabolic acidosis rather than a late complication. This respiratory alkalosis can partially mask the severity of underlying metabolic derangements, necessitating careful interpretation of blood gas parameters rather than relying solely on clinical respiratory assessment. Comprehensive management protocols incorporating these principles have significantly reduced mortality rates compared to historical outcomes, particularly when implemented promptly following confirmed or suspected significant exposures.
Document 3 (Title: Management of Cardiac Glycoside Poisoning): Acute cardiac glycoside intoxication represents a potentially life-threatening toxicological emergency requiring rapid intervention based on established management principles. In cases of significant digitoxin exposure, such as the 8 mg ingestion scenario representing approximately 40 times the typical daily therapeutic dose, multiple interventions assume critical importance. Electrolyte derangements represent a primary concern, with comprehensive treatment protocols emphasizing intensive monitoring of serum potassium levels due to the biphasic pattern frequently observed: initial hyperkalemia from Na+/K+ ATPase inhibition followed by potential hypokalemia during recovery phases. Early decontamination through gastric lavage demonstrates particular efficacy for digitoxin specifically, as its delayed absorption profile provides an extended window for meaningful intervention compared to other cardiac glycosides. Continuous cardiac monitoring represents an essential component of management, with particular attention to dysrhythmias including bradyarrhythmias, AV blocks, and bidirectional ventricular tachycardia requiring immediate intervention through appropriate antiarrhythmic approaches. The management approach notably differs from other poisonings in that forced diuresis, including osmotic approaches, demonstrates minimal efficacy due to the extensive tissue distribution and protein binding characteristics of digitoxin, making enhanced elimination attempts through these mechanisms largely ineffective. Similarly, fluid management requires careful consideration, with standard potassium-containing maintenance formulations potentially exacerbating cardiac toxicity through interaction with already inhibited Na+/K+ ATPase pumps at the myocardial level. The extended half-life of digitoxin necessitates prolonged monitoring periods with continued attention to delayed manifestations that may emerge 12-24 hours following ingestion despite initially stable presentations.

Answer the following list question.
Question: Select the correct statement(s) regarding paracetamol poisoning:
Options:
1. Early administration of activated charcoal decreases the bioavailability of paracetamol
2. N-acetylcysteine used orally, in combination with activated charcoal, loses its detoxifying activity
3. Acute tubular nephropathy constitutes an early sign of intoxication
4. Early gastric lavage constitutes an essential therapeutic measure
5. The toxifying metabolic pathway uses cytochrome P450

Respond strictly in valid JSON format as shown below:
{"answer": ["1", "3"]} ‚Üê if options 1 and 3 are correct
Only output the JSON object. Do not include explanations, labels, markdown, or any other text.